Douglas Kim Graham
Physician at Peakview Pl, Denver, CO
License number
Colorado 36958
Issued Date
May 14, 1998
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
16860 E Peakview Pl, Denver, CO 80016
Professional information
Dr. Douglas K Graham, Aurora CO - MD (Doctor of Medicine)
Address:
13123 E 16 Ave, Aurora 80045
(720) 777-6740 (Phone)
(720) 777-6740 (Phone)
Hospitals:
13123 E 16 Ave, Aurora 80045
University Hospital
234 Goodman St, Cincinnati 45219
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical Schools
University Of North Carolina At Chapel Hill School Of Medicine
Graduated: 1996
University Of North Carolina At Chapel Hill School Of Medicine
Graduated: 1996
Regional Sales Manager At Profile Products
Position:
Regional Sales Manager at Profile Products
Location:
Greater Denver Area
Industry:
Environmental Services
Work:
Profile Products
-
Regional Sales Manager
Education:
University of Oregon 1976 - 1981
Bachelor of Landscape Architecture, Landscape Architecture, Geomorphology
Bachelor of Landscape Architecture, Landscape Architecture, Geomorphology
Douglas Kim Graham, Aurora CO
Specialties:
Pediatric Hematologist / Oncologist
Address:
13123 E 16Th Ave, Aurora, CO 80045
Education:
University of North Carolina, School of Medicine - Doctor of Medicine
University of North Carolina, School of Medicine - Doctor of Philosophy
Children's Hospital, The - Fellowship - Hematology and Oncology (Internal Medicine)
Children's Hospital, The - Residency - Pediatrics
University of North Carolina, School of Medicine - Doctor of Philosophy
Children's Hospital, The - Fellowship - Hematology and Oncology (Internal Medicine)
Children's Hospital, The - Residency - Pediatrics
Methods And Compounds For Enhancing Anti-Cancer Therapy
US Patent:
2012023, Sep 13, 2012
Filed:
Jul 29, 2009
Appl. No.:
13/055101
Inventors:
Douglas Kim Graham - Aurora CO, US
Rachel Linger - Denver CO, US
Deborah Deryckere - Boulder CO, US
Susan Louise Sather - Denver CO, US
Amy Keating - Denver CO, US
Grace Kim - Aurora CO, US
Luis Brandao - Denver CO, US
Rachel Linger - Denver CO, US
Deborah Deryckere - Boulder CO, US
Susan Louise Sather - Denver CO, US
Amy Keating - Denver CO, US
Grace Kim - Aurora CO, US
Luis Brandao - Denver CO, US
International Classification:
A61K 39/395, A61P 35/00, C12N 5/09
US Classification:
4241341, 4241581, 435375
Abstract:
The invention provides methods of treating neoplastic disorders in a mammal through the inhibition of Mer and/or AxI receptor tyrosine kinases as well as compounds and compositions useful for inhibiting these kinases in these methods. These treatment methods may be combined with the administration of one or more chemo therapeutic agent(s) to enhance the efficacy or minimize the toxicities of the chemotherapeutic agent(s).
Axl Tyrosine Kinase Inhibitors And Methods Of Making And Using The Same
US Patent:
2012023, Sep 13, 2012
Filed:
Apr 4, 2012
Appl. No.:
13/439176
Inventors:
Douglas Kim GRAHAM - Aurora CO, US
Susan Louise SATHER - Denver CO, US
Susan Louise SATHER - Denver CO, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO - Denver CO
International Classification:
A61K 39/395, A61P 35/00, A61P 35/02, C07K 19/00
US Classification:
4241341, 5303873
Abstract:
Disclosed are novel inhibitors of the Axl receptor tyrosine kinase (RTK) and methods of using such inhibitors in a variety of therapeutic approaches in the areas of cancer therapy and anti-thrombosis (anti-clotting) therapy.
Axl Fusion Proteins As Axl Tyrosine Kinase Inhibitors
US Patent:
8168415, May 1, 2012
Filed:
Feb 7, 2008
Appl. No.:
12/526094
Inventors:
Douglas Kim Graham - Aurora CO, US
Susan Louise Sather - Denver CO, US
Susan Louise Sather - Denver CO, US
Assignee:
The Regents of the University of Colorado - Denver CO
International Classification:
A61K 39/21, A61K 38/54
US Classification:
435188, 424 943
Abstract:
Disclosed are novel inhibitors of the Axl receptor tyrosine kinase (RTK) and methods of using such inhibitors in a variety of therapeutic approaches in the areas of cancer therapy and anti-thrombosis (anti-clotting) therapy.
Mer Diagnostic And Therapeutic Agents
US Patent:
2008026, Oct 30, 2008
Filed:
Nov 23, 2005
Appl. No.:
11/720185
Inventors:
Douglas Kim Graham - Aurora CO, US
Susan Louise Sather - Denver CO, US
Susan Louise Sather - Denver CO, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO - Boulder CO
International Classification:
A61K 39/395, C12Q 1/48, G01N 33/53, C12N 9/12, A61P 31/00, A61K 38/00, A61K 39/00, C07K 16/18
US Classification:
4241721, 435 15, 435 721, 4241841, 5303881, 5303877, 435194, 514 12
Abstract:
Mer diagnostic and therapeutic agents are disclosed. The agents are useful in the diagnosis and treatment of a variety of diseases including leukemia, lymphoma, and clotting disorders.
Mer Diagnostic And Therapeutic Agents
US Patent:
2012013, May 31, 2012
Filed:
Sep 12, 2011
Appl. No.:
13/230005
Inventors:
Douglas Kim GRAHAM - Aurora CO, US
Susan Louise SATHER - Denver CO, US
Susan Louise SATHER - Denver CO, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate - Denver CO
International Classification:
G01N 33/574, C12Q 1/48
US Classification:
435 723, 435 15
Abstract:
Mer diagnostic and therapeutic agents are disclosed. The agents are useful in the diagnosis and treatment of a variety of diseases including leukemia, lymphoma, and clotting disorders.